Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 47,256 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Follow-Up Questions
What is the price performance of MCVEY stock?
The current price of MCVEY is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Medicover AB?
Medicover AB belongs to Health Care industry and the sector is Health Care
What is Medicover AB market cap?
Medicover AB's current market cap is $0
Is Medicover AB a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for Medicover AB, including 2 strong buy, 4 buy, 4 hold, 0 sell, and 2 strong sell
